Basilea's Toctino approved in Switzerland for severe hand eczema
This article was originally published in Scrip
Executive Summary
Basilea Pharmaceutica's Toctino (alitretinoin), a new once-daily oral treatment for adults with severe chronic hand eczema (CHE), has been approved by the Swiss regulatory authority Swissmedic.